Broccoli, Peas and PIN
A Human Intervention Trial Studying Gene Expression in High-Grade Prostatic Intraepithelial Neoplasia Following Consumption of Broccoli or Peas
3 other identifiers
interventional
22
0 countries
N/A
Brief Summary
This is a parallel human intervention trial to determine to what extent a dietary intervention of broccoli or peas can change the expression (switching on or off) of genes in prostate tissue in men diagnosed with high-grade Prostate Intraepithelial Neoplasia (PIN).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2005
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
September 26, 2007
CompletedFirst Posted
Study publicly available on registry
September 27, 2007
CompletedSeptember 27, 2007
September 1, 2007
September 26, 2007
September 26, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in gene expression in RNA extracted from prostate tissue
Baseline, 6 months and 12 months
Secondary Outcomes (1)
Changes in levels of serum prostate specific antigen (PSA)
Baseline, 6 months and 12 months
Study Arms (2)
1
EXPERIMENTALDietary intervention of ITC-enriched broccoli
2
EXPERIMENTALDietary intervention of frozen peas
Interventions
Eligibility Criteria
You may qualify if:
- Men with a previous diagnosis of high-grade Prostatic Intraepithelial Neoplasia
- BMI \>18.5 or \<35
- Aged between 30-70 years
You may not qualify if:
- Undergoing chemopreventive therapy
- Receiving testosterone replacement medicines
- Active infection requiring treatment
- BMI \<18.5 or \>35
- Diagnosed with diabetes
- Unable to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (11)
Chiao JW, Chung FL, Kancherla R, Ahmed T, Mittelman A, Conaway CC. Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int J Oncol. 2002 Mar;20(3):631-6. doi: 10.3892/ijo.20.3.631.
PMID: 11836580BACKGROUNDCotton SC, Sharp L, Little J, Brockton N. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol. 2000 Jan 1;151(1):7-32. doi: 10.1093/oxfordjournals.aje.a010124.
PMID: 10625170BACKGROUNDFenwick GR, Heaney RK, Mullin WJ. Glucosinolates and their breakdown products in food and food plants. Crit Rev Food Sci Nutr. 1983;18(2):123-201. doi: 10.1080/10408398209527361. No abstract available.
PMID: 6337782BACKGROUNDGamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N, Tulliez J, Terce F. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res. 2000 Mar 1;60(5):1426-33.
PMID: 10728709BACKGROUNDGiovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1403-9.
PMID: 14693729BACKGROUNDHecht SS. Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev. 2000 Aug-Nov;32(3-4):395-411. doi: 10.1081/dmr-100102342.
PMID: 11139137BACKGROUNDHintze KJ, Keck AS, Finley JW, Jeffery EH. Induction of hepatic thioredoxin reductase activity by sulforaphane, both in Hepa1c1c7 cells and in male Fisher 344 rats. J Nutr Biochem. 2003 Mar;14(3):173-179. doi: 10.1016/s0955-2863(02)00282-6.
PMID: 12742546BACKGROUNDKey TJ, Silcocks PB, Davey GK, Appleby PN, Bishop DT. A case-control study of diet and prostate cancer. Br J Cancer. 1997;76(5):678-87. doi: 10.1038/bjc.1997.445.
PMID: 9303371BACKGROUNDMithen R, Faulkner K, Magrath R, Rose P, Williamson G, Marquez J. Development of isothiocyanate-enriched broccoli, and its enhanced ability to induce phase 2 detoxification enzymes in mammalian cells. Theor Appl Genet. 2003 Feb;106(4):727-34. doi: 10.1007/s00122-002-1123-x. Epub 2002 Oct 24.
PMID: 12596003BACKGROUNDSurh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003 Oct;3(10):768-80. doi: 10.1038/nrc1189.
PMID: 14570043BACKGROUNDTraka M, Gasper AV, Melchini A, Bacon JR, Needs PW, Frost V, Chantry A, Jones AM, Ortori CA, Barrett DA, Ball RY, Mills RD, Mithen RF. Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostate. PLoS One. 2008 Jul 2;3(7):e2568. doi: 10.1371/journal.pone.0002568.
PMID: 18596959DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard F Mithen, PhD
Institute of Food Research, Norwich
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 26, 2007
First Posted
September 27, 2007
Study Start
April 1, 2005
Study Completion
April 1, 2007
Last Updated
September 27, 2007
Record last verified: 2007-09